Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In the world economic growth, the Artificial Tears Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Artificial Tears market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Artificial Tears market size will be further expanded, we expect that by 2024, The market size of the Artificial Tears will reach XXX million $.
Artificial tears are lubricating eye drops used to relieve dryness and irritation of the ocular surface. Artificial tears contain carboxymethylcellulose, dextran, glycerin, hypromellose, polyethylene glycol 400 (PEG 400), polysorbate, polyvinyl alcohol, povidone, or propylene glycol.
Increasing prevalence of dry eye syndrome is expected to propel growth of the global artificial tears market over the forecast period. For instance, according to the study, “Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study”, published in BMC Ophthalmology, in January 2020, the prevalence of dry eye disease was 64% in the study population.
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Increasing use of smartphones and other electronic gadgets is expected to offer lucrative growth opportunities for players in the global artificial tears market. For instance, according to the Pew Research Center, as of February 2019, 81% of U.S. adults used smartphones compared to 77% in October 2018. Moreover, R&D in artificial tears is also expected to aid in growth of the market. For instance, in March 2020, researchers from Universidad Michoacana de San Nicolás de Hidalgo, Mexico, reported the development of a portable automated teardrop microinjection system as a practical solution for patients suffering from severe dry eye.
The market is witnessing the development of artificial tears similar to natural tears. For instance, in April 2018, researchers from Complutense University of Madrid, Spain, reported the development of a nano-liposome formulation for dry eyes with components similar to the preocular tear film.
Use of artificial tears may prevent the occurrence of ocular surface disease. For instance, according to the study, “Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?” published in the Journal of the European Academy of Dermatology and Venerology, in January 2020, use of artificial tears may prevent the occurrence of ocular surface disease in patients with severe atopic dermatitis undergoing treatment with dupilumab.
Key Takeaways:
- Increasing prevalence of dry eye syndrome to augment growth of the global artificial tears market over the forecast period
- Major players in the market are focused on launching new products to expand their product portfolio. For instance, in October 2019, Allergan Plc launched Refresh Relieva lubricant eye drop product line to expand its Refresh portfolio. The product is formulated with HydroCell technology to relieve discomfort due to eye dryness and to prevent further irritation.
- Major players operating in the global artificial tears market include, Allergan PLC, Alcon (Novartis), Bausch & Lomb, Abbott Laboratories, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Johnson & Johnson, Ocusoft, Nicox, Sintong, Wuhan Yuanda, and Jiangxi Zhenshiming
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
➟ Allergan
➟ Alcon (Novartis)
➟ Bausch & Lomb
➟ Abbott
➟ Santen Pharmaceutical
➟ Ursapharm
➟ Rohto
➟ Similasan Corporation
➟ Johnson & Johnson
➟ Ocusoft
➟ Nicox
➟ Sintong
➟ Wuhan Yuanda
➟ Jiangxi Zhenshiming
Section 4: Region Segmentation
➟ North America Country (United States, Canada)
➟ South America
➟ Asia Country (China, Japan, India, Korea)
➟ Europe Country (Germany, UK, France, Italy)
➟ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
➟ Artificial Tear Liquid
➟ Artificial Tear Ointment
Industry Segmentation:
➟ Dry Eyes Treatment
➟ Contact Lenses Moisten
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
